{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:09:18Z","timestamp":1775030958332,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Biophysics and Molecular Biology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.pbiomolbio.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,2,19]],"date-time":"2020-02-19T19:49:42Z","timestamp":1582141782000},"page":"2-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Introduction: Novel insights into TB research and drug discovery"],"prefix":"10.1016","volume":"152","author":[{"given":"Gerhard","family":"Gr\u00fcber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A\u00a0diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102135","article-title":"Acquired resistance of Mycobacterium tuberculosis to bedaquiline","volume":"9","author":"Andries","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005190","article-title":"Essential role of the ESX-5 secretion system in outer membrane permeability of pathogenic mycobacteria","volume":"11","author":"Ates","year":"2015","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.pbiomolbio.2020.02.003_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00272-17","article-title":"Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery","volume":"8","author":"Bald","year":"2017","journal-title":"mBio"},{"issue":"4568","key":"10.1016\/j.pbiomolbio.2020.02.003_bib33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/1791013a0","article-title":"A\u00a0new series of phenazines (rimino-compounds) with high antituberculosis activity","volume":"179","author":"Barry","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib5","doi-asserted-by":"crossref","first-page":"17047","DOI":"10.1038\/nmicrobiol.2017.47","article-title":"Structure of the mycobacterial ESX-5 type VII secretion system membrane complex by single-particle analysis","volume":"2","author":"Beckham","year":"2017","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01275-14","article-title":"A\u00a0Mycobacterium tuberculosis cytochrome bd oxidase mutant is hypersensitive to bedaquiline","volume":"5","author":"Berney","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib7","first-page":"2329","article-title":"Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline","volume":"61","author":"Blaser","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib8","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev.micro.112408.134043","article-title":"Letting sleeping dos lie: does dormancy play a role in tuberculosis?","volume":"64","author":"Chao","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib9","doi-asserted-by":"crossref","first-page":"5190","DOI":"10.1016\/j.bmcl.2017.10.042","article-title":"Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units","volume":"27","author":"Choi","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0015-2013","article-title":"Energetics of respiration and oxidative phosphorylation in mycobacteria","volume":"2","author":"Cook","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrmicro2128","article-title":"Antimicrobial mechanisms of phagocytes and bacterial evasion strategies","volume":"7","author":"Flannagan","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib12","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/acsinfecdis.7b00079","article-title":"Pyrazinoic acid inhibits mycobacterial coenzyme A biosynthesis by binding to aspartate decarboxylase PanD","volume":"3","author":"Gopal","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib13","series-title":"Pyrazinamide Triggers Degradation of its Target Aspartate Decarboxylase","first-page":"674416","author":"Gopal","year":"2019"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1574-6968.2010.02123.x","article-title":"ATP synthase in slow- and fast-growing mycobacteria is active in ATP synthesis and blocked in ATP hydrolysis direction","volume":"313","author":"Haagsma","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib15","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/jac\/dkv054","article-title":"Bactericidal mode of action of bedaquiline","volume":"70","author":"Hards","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib16","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1128\/AAC.00037-14","article-title":"Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis","volume":"58","author":"Hartkoorn","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib17","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/febs.13715","article-title":"Deletion of a unique loop in the mycobacterial F-ATP synthase \u03b3 subunit sheds light in its inhibitory role in ATP hydrolysis driven H+-pumping","volume":"283","author":"Hotra","year":"2016","journal-title":"FEBS J."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib18","doi-asserted-by":"crossref","first-page":"7426","DOI":"10.1073\/pnas.1706139114","article-title":"Exploiting the synthetic lethality between terminal respiratory oxidases to kill Mycobacterium tuberculosis and clear host infection","volume":"114","author":"Kalia","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib19","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1038\/ncomms12393","article-title":"Turning the respiratory flexibility of Mycobacterium tuberculosis against itself","volume":"7","author":"Lamprecht","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib20","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1038\/srep10333","article-title":"The cytochrome bd-type quinol oxidase is important for survival of Mycobacterium smegmatis under peroxide and antibiotic-induced stress","volume":"5","author":"Lu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0041-3879(85)90040-6","article-title":"The action of antituberculosis drugs in short-course chemotherapy","volume":"66","author":"Mitchison","year":"1985","journal-title":"Tubercle"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib22","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.1038\/s41598-018-31850-3","article-title":"Structures of Mycobacterium smegmatis 70S ribosomes in complex with HPF, tmRNA, and P-tRNA","volume":"8","author":"Mishra","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.pbiomolbio.2020.02.003_bib34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib23","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1073\/pnas.0711697105","article-title":"The proton motive force is required for maintaining ATP homoeostasis and viability of hypoxis, nonreplicting Mycobacterium tuberculosis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.20030846","article-title":"Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment","volume":"198","author":"Schnappinger","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01073-14","article-title":"Mycobacterial Esx-3 requires multiple components for iron acquisition","volume":"5","author":"Siegrist","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib27","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.bmc.2018.02.026","article-title":"Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles","volume":"26","author":"Sutherland","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib28","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.bmc.2019.02.026","article-title":"3, 5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel","volume":"27","author":"Sutherland","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib30","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1021\/acsmedchemlett.7b00196","article-title":"6-Cyano analogues of bedaquiline as less lipophilic and potentially safer diarylquinolines for tuberculosis","volume":"8","author":"Tong","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.pbiomolbio.2020.02.003_bib31","series-title":"Global Tuberculosis Report 2018","author":"World Health Organization","year":"2018"}],"container-title":["Progress in Biophysics and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610720300110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079610720300110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T21:47:20Z","timestamp":1758750440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079610720300110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":32,"alternative-id":["S0079610720300110"],"URL":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2020.02.003","relation":{},"ISSN":["0079-6107"],"issn-type":[{"value":"0079-6107","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Introduction: Novel insights into TB research and drug discovery","name":"articletitle","label":"Article Title"},{"value":"Progress in Biophysics and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbiomolbio.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}